KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Tax Provisions (2021 - 2025)

Historic Tax Provisions for Dynavax Technologies (DVAX) over the last 5 years, with Q3 2025 value amounting to $1.5 million.

  • Dynavax Technologies' Tax Provisions fell 3291.37% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 2566.51%. This contributed to the annual value of $3.5 million for FY2024, which is 7537.09% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' Tax Provisions is $1.5 million, which was down 3291.37% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Tax Provisions ranged from a high of $3.5 million in Q2 2024 and a low of -$2.8 million during Q1 2024
  • Moreover, its 5-year median value for Tax Provisions was $619000.0 (2022), whereas its average is $648266.7.
  • Over the last 5 years, Dynavax Technologies' Tax Provisions had its largest YoY gain of 161292.52% in 2024, and its largest YoY loss of 55454.55% in 2024.
  • Dynavax Technologies' Tax Provisions (Quarter) stood at $808000.0 in 2021, then crashed by 70.17% to $241000.0 in 2022, then surged by 222.41% to $777000.0 in 2023, then decreased by 25.48% to $579000.0 in 2024, then surged by 157.69% to $1.5 million in 2025.
  • Its Tax Provisions stands at $1.5 million for Q3 2025, versus $2.5 million for Q2 2025 and -$1.8 million for Q1 2025.